ARTICLE | Company News
Urigen genitourinary news
May 4, 2009 7:00 AM UTC
Urigen is seeking strategic alternatives, including the license or formation of a JV around its URG101 and URG301. URG101 is an intravesical formulation of heparin and alkalinized lidocaine for pain...